Efficacy of hydroxyurea in providing transfusion independence in β-thalassemia. (otvara se novi prozor)

Ansari SH, Shamsi TS, Ashraf M, Perveen K, Farzana T, Bohray M, Erum S, Mehboob T.

Izvor‎: J Pediatr Hematol Oncol 2011;33(5):339-43.

Indeks‎: PubMed 21602718

DOI‎: 10.1097/MPH.0b013e31821b0770

https://www.ncbi.nlm.nih.gov/pubmed/21602718 (otvara se novi prozor)

Hydroxyurea treatment in β-thalassemia patients: to respond or not to respond? (otvara se novi prozor)

Banan M.

Izvor‎: Ann Hematol 2013;92(3):289-99.

Indeks‎: PubMed 23318979

DOI‎: 10.1007/s00277-012-1671-3

https://www.ncbi.nlm.nih.gov/pubmed/23318979 (otvara se novi prozor)

Decreased transfusion needs associated with hydroxyurea therapy in Algerian patients with thalassemia major or intermedia. (otvara se novi prozor)

Bradai M, Pissard S, Abad MT, Dechartres A, Ribeil JA, Landais P, de Montalembert M.

Izvor‎: Transfusion 2007;47(10):1830-6.

Indeks‎: PubMed 17880608

DOI‎: 10.1111/j.1537-2995.2007.01399.x

https://www.ncbi.nlm.nih.gov/pubmed/17880608 (otvara se novi prozor)

Hydroxyurea increases hemoglobin F levels and improves the effectiveness of erythropoiesis in beta-thalassemia/hemoglobin E disease. (otvara se novi prozor)

Fucharoen S, Siritanaratkul N, Winichagoon P, Chowthaworn J, Siriboon W, Muangsup W, Chaicharoen S, Poolsup N, Chindavijak B, Pootrakul P, Piankijagum A, Schechter AN, Rodgers GP.

Izvor‎: Blood 1996;87(3):887-92.

Indeks‎: PubMed 8562958

https://www.ncbi.nlm.nih.gov/pubmed/8562958 (otvara se novi prozor)

Hydroxyurea can reduce or eliminate transfusion requirements in children with major and intermediate thalassemia. (otvara se novi prozor)

Hashemi A, Abrishamkar M, Jenabzade AR, Eslami Z.

Izvor‎: Iran J Blood Cancer 2009;1(4):147-50.

Indeks‎: IMEMR 107228

https://www.ijbc.ir/browse.php?a_id=4&sid=1&slc_lang=en (otvara se novi prozor)

Hydroxyurea as a first-line treatment of extramedullary hematopoiesis in patients with beta thalassemia: Four case reports. (otvara se novi prozor)

Karimi M, Cohan N, Pishdad P.

Izvor‎: Hematology 2015;20(1):53-7.

Indeks‎: PubMed 24717020

DOI‎: 10.1179/1607845414Y.0000000168

https://www.ncbi.nlm.nih.gov/pubmed/24717020 (otvara se novi prozor)

Genotype-phenotype relationship of patients with β-thalassemia taking hydroxyurea: a 13-year experience in Iran. (otvara se novi prozor)

Karimi M, Haghpanah S, Farhadi A, Yavarian M.

Izvor‎: Int J Hematol 2012;95(1):51-6.

Indeks‎: PubMed 22180324

DOI‎: 10.1007/s12185-011-0985-6

https://www.ncbi.nlm.nih.gov/pubmed/22180324 (otvara se novi prozor)

Report on Patients with Non Transfusion-Dependent β-Thalassemia Major Being Treated with Hydroxyurea Attending the Thalassemia Research Center, Sari, Mazandaran Province, Islamic Republic of Iran in 2013. (otvara se novi prozor)

Kosaryan M, Karami H, Zafari M, Yaghobi N.

Izvor‎: Hemoglobin 2014;38(2):115-8.

Indeks‎: PubMed 24471558

DOI‎: 10.3109/03630269.2013.869229

https://www.ncbi.nlm.nih.gov/pubmed/24471558 (otvara se novi prozor)

Clinical experience with fetal hemoglobin induction therapy in patients with β-thalassemia. (otvara se novi prozor)

Musallam KM, Taher AT, Cappellini MD, Sankaran VG.

Izvor‎: Blood 2013;121(12):2199-212.

Indeks‎: PubMed 23315167

DOI‎: 10.1182/blood-2012-10-408021

https://www.ncbi.nlm.nih.gov/pubmed/23315167 (otvara se novi prozor)

A randomised double-blind placebo-controlled clinical trial of oral hydroxyurea for transfusion-dependent β-thalassaemia. (otvara se novi prozor)

Yasara N, Wickramarathne N, Mettananda C, Silva I, Hameed N, Attanayaka K, Rodrigo R, Wickramasinghe N, Perera L, Manamperi A, Premawardhena A, Mettananda S

Izvor‎: Sci Rep. 2022;12(1):2752.

Indeks‎: PubMed 35177777

DOI‎: 10.1038/s41598-022-06774-8

https://pubmed.ncbi.nlm.nih.gov/35177777/ (otvara se novi prozor)

Response to hydroxyurea treatment in Iranian transfusion-dependent beta-thalassemia patients. (otvara se novi prozor)

Yavarian M, Karimi M, Bakker E, Harteveld CL, Giordano PC.

Izvor‎: Haematologica 2004;89(10):1172-8.

Indeks‎: PubMed 15477200

https://www.ncbi.nlm.nih.gov/pubmed/15477200 (otvara se novi prozor)

Hydroxyurea therapy in 49 patients with major beta-thalassemia. (otvara se novi prozor)

Zamani F, Shakeri R, Eslami SM, Razavi SM, Basi A.

Izvor‎: Arch Iran Med 2009;12(3):295-7.

Indeks‎: PubMed 19400608

https://www.ncbi.nlm.nih.gov/pubmed/19400608 (otvara se novi prozor)

Preliminary results with administration of recombinant human erythropoietin in sickle cell/beta-thalassemia patients during pregnancy. (otvara se novi prozor)

Bourantas K, Makrydimas G, Georgiou J, Tsiara S, Lolis D.

Izvor‎: Eur J Haematol 1996;56(5):326-8.

Indeks‎: PubMed 8641410

https://www.ncbi.nlm.nih.gov/pubmed/8641410 (otvara se novi prozor)

Induction of fetal hemoglobin synthesis with recombinant human erythropoietin in anemic patients with heterozygous beta-thalassemia during pregnancy. (otvara se novi prozor)

Breymann C, Fibach E, Visca E, Huettner C, Huch A, Huch R.

Izvor‎: J Matern Fetal Med 1999;8(1):1-7.

Indeks‎: PubMed 10052837

DOI‎: 10.1002/(SICI)1520-6661(199901/02)8:1<1::AID-MFM1>3.0.CO;2-O

https://www.ncbi.nlm.nih.gov/pubmed/10052837 (otvara se novi prozor)

Treatment of beta-thalassemia patients with recombinant human erythropoietin: effect on transfusion requirements and soluble adhesion molecules. (otvara se novi prozor)

Chaidos A, Makis A, Hatzimichael E, Tsiara S, Gouva M, Tzouvara E, Bourantas KL.

Izvor‎: Acta Haematol 2004;111(4):189-95.

Indeks‎: PubMed 15153710

DOI‎: 10.1159/000077551

https://www.ncbi.nlm.nih.gov/pubmed/15153710 (otvara se novi prozor)

Recombinant human erythropoietin therapy in a transfusion-dependent β-thalassemia major patient. (otvara se novi prozor)

Makis AC, Chaliasos N, Hatzimichael EC, Bourantas KL.

Izvor‎: Ann Hematol 2001;80(8):492-5.

Indeks‎: PubMed 11563599

https://www.ncbi.nlm.nih.gov/pubmed/11563599 (otvara se novi prozor)

Fetal globin induction--can it cure beta thalassemia? (otvara se novi prozor)

Perrine SP.

Izvor‎: Hematology Am Soc Hematol Educ Program 2005:38-44.

Indeks‎: PubMed 16304357

DOI‎: 10.1182/asheducation-2005.1.38

https://www.ncbi.nlm.nih.gov/pubmed/16304357 (otvara se novi prozor)